Physician profile
Mike Gonce
NPI 1356300784
$10,027.86
in general payments reported to CMS, 2019-2025
7 companies · $557 in 2025
The $557 reported for 2025 was more than what 81% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,106 · 2020: $208 · 2021: $175 · 2022: $414 · 2023: $217 · 2024: $2,352 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $2,457 · Food and Beverage: $668.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $2,457.17 |
| Food and Beverage | $668.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $6,705.02 | 2019-2022 | |
| Johnson & Johnson Health Care Systems INC. | $2,457.17 | 2024-2025 | |
| Abbvie INC. | $583.24 | 2023-2025 | |
| Mentor Worldwide LLC | $170.04 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Tepha INC | $70.12 | 2019-2020 | |
| Sientra, INC. | $23.90 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $18.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mike Gonce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.